Compile Data Set for Download or QSAR
Report error Found 19 Enz. Inhib. hit(s) with all data for entry = 13000
TargetMyelin transcription factor 1(Human)
Insilico Medicine Ip

US Patent
LigandPNGBDBM749296(US20250188094, Example 2)
Affinity DataIC50: 10nMAssay Description:Compound serial dilution was performed by Echo, and the final concentrations vary from 10 μM to 0.5 nM. This was filled by the addition of 5 μL/well ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Insilico Medicine Ip

US Patent
LigandPNGBDBM749295(US20250188094, Example 1)
Affinity DataIC50: 10nMAssay Description:Compound serial dilution was performed by Echo, and the final concentrations vary from 10 μM to 0.5 nM. This was filled by the addition of 5 μL/well ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Insilico Medicine Ip

US Patent
LigandPNGBDBM749303(US20250188094, Example 9)
Affinity DataIC50: 10nMAssay Description:Compound serial dilution was performed by Echo, and the final concentrations vary from 10 μM to 0.5 nM. This was filled by the addition of 5 μL/well ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Insilico Medicine Ip

US Patent
LigandPNGBDBM749300(US20250188094, Example 6)
Affinity DataIC50: 10nMAssay Description:Compound serial dilution was performed by Echo, and the final concentrations vary from 10 μM to 0.5 nM. This was filled by the addition of 5 μL/well ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Insilico Medicine Ip

US Patent
LigandPNGBDBM749299(US20250188094, Example 5)
Affinity DataIC50: 10nMAssay Description:Compound serial dilution was performed by Echo, and the final concentrations vary from 10 μM to 0.5 nM. This was filled by the addition of 5 μL/well ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Insilico Medicine Ip

US Patent
LigandPNGBDBM749298(US20250188094, Example 4)
Affinity DataIC50: 10nMAssay Description:Compound serial dilution was performed by Echo, and the final concentrations vary from 10 μM to 0.5 nM. This was filled by the addition of 5 μL/well ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Insilico Medicine Ip

US Patent
LigandPNGBDBM749297(US20250188094, Example 3)
Affinity DataIC50: 10nMAssay Description:Compound serial dilution was performed by Echo, and the final concentrations vary from 10 μM to 0.5 nM. This was filled by the addition of 5 μL/well ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Insilico Medicine Ip

US Patent
LigandPNGBDBM749304(US20250188094, Example 10)
Affinity DataIC50: 30nMAssay Description:Compound serial dilution was performed by Echo, and the final concentrations vary from 10 μM to 0.5 nM. This was filled by the addition of 5 μL/well ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Insilico Medicine Ip

US Patent
LigandPNGBDBM749301(US20250188094, Example 7)
Affinity DataIC50: 30nMAssay Description:Compound serial dilution was performed by Echo, and the final concentrations vary from 10 μM to 0.5 nM. This was filled by the addition of 5 μL/well ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Insilico Medicine Ip

US Patent
LigandPNGBDBM749305(US20250188094, Example 11)
Affinity DataIC50: 275nMAssay Description:Compound serial dilution was performed by Echo, and the final concentrations vary from 10 μM to 0.5 nM. This was filled by the addition of 5 μL/well ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Insilico Medicine Ip

US Patent
LigandPNGBDBM749295(US20250188094, Example 1)
Affinity DataIC50: 275nMAssay Description:Compound serial dilution is performed by Echo, and the final concentrations vary from 10 μM to 0.5 nM. This was filled by the addition of 5 μL/well o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Insilico Medicine Ip

US Patent
LigandPNGBDBM749303(US20250188094, Example 9)
Affinity DataIC50: 275nMAssay Description:Compound serial dilution is performed by Echo, and the final concentrations vary from 10 μM to 0.5 nM. This was filled by the addition of 5 μL/well o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetMyelin transcription factor 1(Human)
Insilico Medicine Ip

US Patent
LigandPNGBDBM749302(US20250188094, Example 8)
Affinity DataIC50: 275nMAssay Description:Compound serial dilution was performed by Echo, and the final concentrations vary from 10 μM to 0.5 nM. This was filled by the addition of 5 μL/well ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Insilico Medicine Ip

US Patent
LigandPNGBDBM749300(US20250188094, Example 6)
Affinity DataIC50: 275nMAssay Description:Compound serial dilution is performed by Echo, and the final concentrations vary from 10 μM to 0.5 nM. This was filled by the addition of 5 μL/well o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Insilico Medicine Ip

US Patent
LigandPNGBDBM749297(US20250188094, Example 3)
Affinity DataIC50: 275nMAssay Description:Compound serial dilution is performed by Echo, and the final concentrations vary from 10 μM to 0.5 nM. This was filled by the addition of 5 μL/well o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Insilico Medicine Ip

US Patent
LigandPNGBDBM749296(US20250188094, Example 2)
Affinity DataIC50: 275nMAssay Description:Compound serial dilution is performed by Echo, and the final concentrations vary from 10 μM to 0.5 nM. This was filled by the addition of 5 μL/well o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Insilico Medicine Ip

US Patent
LigandPNGBDBM749304(US20250188094, Example 10)
Affinity DataIC50: 2.75E+3nMAssay Description:Compound serial dilution is performed by Echo, and the final concentrations vary from 10 μM to 0.5 nM. This was filled by the addition of 5 μL/well o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Insilico Medicine Ip

US Patent
LigandPNGBDBM749301(US20250188094, Example 7)
Affinity DataIC50: 2.75E+3nMAssay Description:Compound serial dilution is performed by Echo, and the final concentrations vary from 10 μM to 0.5 nM. This was filled by the addition of 5 μL/well o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Insilico Medicine Ip

US Patent
LigandPNGBDBM749302(US20250188094, Example 8)
Affinity DataIC50: 5.00E+3nMAssay Description:Compound serial dilution is performed by Echo, and the final concentrations vary from 10 μM to 0.5 nM. This was filled by the addition of 5 μL/well o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent